Stay updated on CJM112 in Hidradenitis Suppurativa Patients Clinical Trial
Sign up to get notified when there's something new on the CJM112 in Hidradenitis Suppurativa Patients Clinical Trial page.

Latest updates to the CJM112 in Hidradenitis Suppurativa Patients Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedAdded Revision: v3.3.3. Removed HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision: v3.3.2 updated on the site, with no visible changes to page content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check57 days agoChange Detected- Added Revision: v3.3.1 and removed Revision: v3.2.0 from the page.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded detailed numerical data and tables for pharmacokinetics (Ctrough), immunogenicity (ADA), and IL-17A levels, along with expanded outcome measures and participant counts for Period 1 and Period 2.SummaryDifference1%

- Check79 days agoChange DetectedMinor formatting and layout updates observed on the Study Results page; core data and sections remain unchanged.SummaryDifference0.0%

- Check109 days agoChange Detected- Version tag updated from v3.0.2 to v3.2.0, indicating a new release.SummaryDifference0.0%

Stay in the know with updates to CJM112 in Hidradenitis Suppurativa Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CJM112 in Hidradenitis Suppurativa Patients Clinical Trial page.